医学
阿达木单抗
免疫原性
葡萄膜炎
系统回顾
内科学
重症监护医学
梅德林
免疫学
肿瘤坏死因子α
抗体
政治学
法学
作者
Victoria Segura Fernández-Nogueras,Laura Morales Hidalgoa,Eva Rodríguez,Ignacio García‐Basterra,P. Rivera de Zea,C. Alba Linero
标识
DOI:10.1080/09273948.2025.2486371
摘要
The association between low SATL, AAA, and poor response to ADA treatment is well established. However, further high-quality investigations are needed to strengthen the evidence in this area. Therapeutic monitoring strategies appear to be valuable tools for providing personalized management for patients with NIU.
科研通智能强力驱动
Strongly Powered by AbleSci AI